Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 17/20 | 0.70 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.39 |
| ▸ | HRH1 | P35367 | 2/20 | 0.39 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.38 |
| ▸ | CDK9 | P50750 | 2/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29221485 | 1.00 | SLC6A2 (0.70) | SLC6A2SLC6A4SLC6A3HRH1CCNT1 | |
| SCHEMBL29221482 | 1.00 | SLC6A2 (0.70) | SLC6A2SLC6A4SLC6A3HRH1CCNT1 | |
| Edivoxetine SCHEMBL13176435 | 0.84 | SLC6A2 (0.89) | SLC6A2SLC6A4SLC6A3HRH1CCNT1 | |
| Edivoxetine SCHEMBL14072285 | 0.84 | SLC6A2 (0.89) | SLC6A2SLC6A4SLC6A3HRH1CCNT1 | |
| Edivoxetine SCHEMBL17662033 | 0.84 | SLC6A2 (0.89) | SLC6A2SLC6A4SLC6A3HRH1CCNT1 | |
| Edivoxetine SCHEMBL2907186 | 0.84 | SLC6A2 (0.89) | SLC6A2SLC6A4SLC6A3HRH1CCNT1 | |
| Edivoxetine SCHEMBL2904573 | 0.83 | SLC6A2 (0.87) | SLC6A2SLC6A4SLC6A3HRH1CCNT1 | |
| SCHEMBL2909340 | 0.82 | SLC6A2 (1.00) | SLC6A2SLC6A4SLC6A3HRH1CCNT1 | |
| Hydrochloric Acid SCHEMBL2907982 | 0.82 | SLC6A2 (0.98) | SLC6A2SLC6A4SLC6A3HRH1CCNT1 | |
| SCHEMBL2908699 | 0.79 | SLC6A2 (0.70) | SLC6A2SLC6A4SLC6A3HRH1CCNT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117615764-A | Norepinephrine reuptake inhibitors for the treatment of sleep apnea | 爱普宁公司(特拉华) | 2024-02-27 | — | — | CN | disclosed |